This inventor holds 2 USPTO granted patents. Top assignee: Eidos Therapeutics, Inc.. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Innovations by Satish Rao in Treating TTR Amyloidosis
Introduction
Satish Rao is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of medicine, particularly in the treatment of transthyretin (TTR) amyloidosis. With a total of 2 patents, his work is paving the way for new therapeutic approaches.
Latest Patents
Satish Rao's latest patents focus on innovative methods for treating TTR amyloidosis using AG10. These patents describe specific dosing regimens that demonstrate great efficacy in treating subjects while being well tolerated. His research aims to improve the quality of life for individuals affected by this condition.
Career Highlights
Satish Rao is currently associated with Eidos Therapeutics, Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to finding effective treatments for complex diseases.
Collaborations
One of his notable coworkers is Uma Sinha, with whom he collaborates on various projects aimed at enhancing therapeutic strategies for TTR amyloidosis.
Conclusion
Satish Rao's innovative work in the treatment of TTR amyloidosis showcases his dedication to improving patient outcomes through scientific research and collaboration. His contributions are vital in the ongoing fight against this challenging disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile